J. Michael Pearson's Net Worth

$246 Million

Estimate Recalculated Sep 9, 2024 03:55PM EST

Who is J. Michael Pearson?

J. Michael Pearson has an estimated net worth of $246 Million. This is based on reported shares across multiple companies, which include Valeant Pharmaceuticals International, Inc., and VALEANT PHARMACEUTICALS INTERNATIONAL.

SEC CIK

J. Michael Pearson's CIK is 0001426004

Past Insider Trading and Trends

2008 was J. Michael Pearson's most active year for acquiring shares with 14 total transactions. J. Michael Pearson's most active month to acquire stocks was the month of January. 2010 was J. Michael Pearson's most active year for disposing of shares, totalling 6 transactions. J. Michael Pearson's most active month to dispose stocks was the month of January. 2011 saw J. Michael Pearson paying a total of $33,390,769.53 for 931,284 shares, this is the most they've acquired in one year. In 2015 J. Michael Pearson cashed out on 1,311,811 shares for a total of $102,889,143.12, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Valeant Pharmaceuticals International, Inc. (BHC) Snapshot price: $6.1229

Chief Executive Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Dec 31
Form 4
-46.14%
-1.30M
$78.48
-$101,825,969.88
1.51M
Nov 5
Form 4
+3.18%
86.64K
—
—
2.81M
Feb 26
Form 4
—
0
—
—
0
Jan 7
Form 4
—
0
—
—
0
Mar 11
Form 4
+4.80%
184.25K
$81.41
$14,999,548.27
4.03M
Dec 14
Form 4
-2.71%
-175.00K
—
—
6.29M
Dec 14
Form 4
-0.40%
-25.79K
—
—
6.46M
Oct 24
Form 4
-1.55%
-101.88K
—
—
6.49M
Apr 24
Form 4
+8.13%
495.7K
—
—
6.59M
Apr 12
Form 4
-0.81%
-49.54K
—
—
6.09M
Feb 1
Form 4
-0.82%
-51.00K
—
—
6.14M
Dec 23
Form 4
+2.79%
155.64K
—
—
5.73M
Oct 24
Form 4
—
0
—
—
0
Aug 23
Form 4
+2.87%
155.64K
$38.62
$6,010,769.53
5.57M
Aug 11
Form 4
-4.17%
-235.79K
$54.05
-$12,744,611.65
5.41M
Apr 21
Form 4
-14.12%
-929.36K
$39.50
-$36,709,878.00
5.65M
Feb 10
Form 4
—
0
—
—
0
Oct 4
Form 4
+157.23%
4.58M
—
—
7.48M
Sep 28
Form 3
—
0
—
—
0
No matching records found

VALEANT PHARMACEUTICALS INTERNATIONAL No price found

CEO and Chairman

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.93M
—
—
0
Sep 28
Form 4
-3.07%
-31.84K
$33.72
-$1,073,644.80
1M
Feb 1
Form 4
-15.42%
-188.88K
$31.93
-$6,030,778.75
1.04M
Dec 7
Form 4
—
0
—
—
0
Dec 1
Form 4
-2.76%
-34.80K
$24.73
-$860,678.19
1.22M
Jul 23
Form 4
+0.56%
7K
$18.51
$129,570.00
1.26M
May 7
Form 4/A
+166.67%
407.5K
—
—
652K
Feb 1
Form 4
+6.48%
51.44K
—
—
845.22K
Aug 11
Form 4
+33.24%
198.01K
—
—
793.78K
Jul 10
Form 4
+14.72%
50.91K
—
—
396.82K
Jun 10
Form 4
+10.43%
51.44K
$16.20
$833,328.00
544.86K
Jul 3
Form 4
+10.97%
48.76K
$17.09
$833,325.49
493.42K
Jun 26
Form 4
+12.34%
48.85K
$17.06
$833,329.82
444.66K
Jun 19
Form 4
+14.43%
49.9K
$16.70
$833,330.00
395.81K
Jun 12
Form 4
+17.10%
50.51K
$16.50
$833,332.50
345.91K
Jun 5
Form 4
+20.82%
50.91K
$16.37
$833,331.22
295.41K
May 30
Form 4
∞
244.5K
—
—
244.5K
Feb 1
Form 3
—
0
—
—
0
No matching records found